- Home
- » Tags
- » Piperacillin
Top View
- Clinical Effectiveness of Ertapenem Versus Piperacillin/Tazobactam In
- ZOSYN® (Piperacillin and Tazobactam for Injection, USP)
- Amoxicillin-Clavulanate IV Is Cost Neutral Compared to Piperacillin-Tazobactam at Usual Doses but Is MORE Expensive Than Ceftriaxone +/- Metronidazole IV/PO
- Antibiotic Streamlining
- Cephalosporins: a Focus on Side Chains and -Lactam Cross-Reactivity
- Gastrointestinal Infection Treatment Guideline
- Treatment Alternatives for Piperacillin/Tazobactam
- Antibiotic Recommendations for Sepsis and Septic Shock
- Ertapenem Once a Day Versus Piperacillin–Tazobactam Every 6 Hours for Treatment of Acute Pelvic Infections: a Prospective, Multicenter, Randomized, Double-Blind Study
- IV to PO Conversion Developed by Dr
- ZOSYN (Piperacillin and Tazobactam)
- PIPERACILLIN and TAZOBACTAM for INJECTION, USP the Richmond-Sykes Class III (Bush Class 2B & 2B') Penicillinases and Cephalosporinases
- P1763 Should We Use Ampicillin to Predict Enterococci Susceptibility to Piperacillin? Anne-Gaëlle Leroy*1, Antoine Rambaud1, Lise Crémet1, Jocelyne Caillon1
- Vancomycin Plus Piperacillin-Tazobactam and Acute Kidney Injury in Adults: a Systematic Review and Meta-Analysis
- Penicillin Allergy Cross-‐Reactivity • Roughly 10% of the Population
- Evaluation of the Antibacterial Activity of Piperacillin–Tazobactam Against Burkholderia Pseudomallei in Vitro
- Therapeutic Drug Monitoring of Meropenem and Piperacillin in Critical Illness—Experience and Recommendations from One Year in Routine Clinical Practice
- Piperacillin-Tazobactam (Zosyn) Dosing Protocol
- 1 Justification and Protocol for Extended-Infusion Piperacillin
- Intravenous to Oral Conversion for Antimicrobials
- IJMM July 07.Indd
- Beta-Lactams Susceptibility Testing of Penicillin-Resistant, Ampicillin
- Analysis of Susceptibility to Selected Antibiotics in Klebsiella
- Strategies for De-Escalation and Optimized Antibiotic Therapy Guillaume Béraud José Ramón Paño University Hospital of Poitiers
- Β-Lactam Susceptibility of Escherichia Coli Isolates from Urinary Tract Infections Exhibiting Different Resistance Phenotypes
- Antimicrobial Use Guidelines
- Empiric Antibiotic Guidelines
- Isolation and Antimicrobial Susceptibility Profile Of
- Determination of Piperacillin/Tazobactam And
- Clinical Efficacy of Ceftaroline Fosamil in Patients with Severe Pneumonia
- Susceptibility Testing Β-Lactamase Inhibitor Combinations
- INFORMATION for the USER Piperacillin/Tazobactam 2 G/0.25 G and 4 G/0.5 G Powder for Solution for Infusion
- Antibiotics in Sepsis: the Basics
- Double Anaerobic Coverage: What Is the Role in Clinical Practice?
- Intra-Hospital Differences in Antibiotic Use Correlate with Antimicrobial
- Y-Site Incompatibility Between Premix Concentrations of Vancomycin and Piperacillin-Tazobactam: Do Current Compatibility Testing Methodologies Tell the Whole Story?
- Alternative Antibiotic Options for Shortage of IV PIPERACILLIN/TAZOBACTAM
- Surgical Antimicrobial Prophylaxis Recommendations
- Empiric Antimicrobial Therapy
- Comparative Effectiveness of Exclusive Exposure to Nafcillin Or
- Invanz® (Ertapenem for Injection)
- Effective in Vitro Synergy of Piperacillin/Tazobactam Plus Either Netilmicin Or Aztreonam Against Metallo-Β-Lactamase-Producing Pseudomonas Aeruginosa
- Treatment of Methicillin-Resistant Staphylococcus Aureus (MRSA) Pneumonia with Ceftaroline Fosamil in a Patient with Inhalational Thermal Injury
- Antibiotic Dosing Guidelines PDF (Surgical )
- Randomized Controlled Trial of Piperacillin-Tazobactam, Cefepime
- INFECTIOUS SYNDROMES COMMENTS (Use As Much Space As You Need)
- Empiric Treatment Guidelines for Common Infections in Adults
- Piperacillin-Tazobactam–Induced Drug Hypersensitivity Syndrome
- Zinforo, INN Ceftaroline Fosamil
- ANMC Antibiotic Guidelines for Gastrointestinal Infection